SCHEMBL22979409

SCHEMBL22979409

N#Cc1c(Br)cccc1NC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.48
WDR77 Q9BQA1 1/20 0.48
CXCR2 P25025 6/20 0.46
CXCR1 P25024 4/20 0.46
KMT2A Q03164 3/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
ADRB3 P13945 1/20 0.38
TSPO P30536 1/20 0.38
SLC6A3 Q01959 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
TAS1R2 Q8TE23 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22979909 0.81 RAB9A (0.44) CXCR2KMT2AMEN1NPC1LMNA
SCHEMBL22987403 0.81 ALDH1A1 (0.52) PRMT5WDR77KMT2AMEN1NPC1
SCHEMBL29649042 0.81 ALDH1A1 (0.52) PRMT5WDR77KMT2AMEN1NPC1
SCHEMBL22979636 0.79 TAS1R3 (0.57) CXCR2KMT2AMEN1NPC1LMNA
SCHEMBL22979854 0.76 ALDH1A1 (0.48) KMT2AHTTMEN1NPC1LMNA
SCHEMBL2097429 0.75 KMT2A (0.66) CXCR2CXCR1KMT2AHTTMEN1
SCHEMBL14157620 0.74 LMNA (0.46) CXCR2CXCR1KMT2AHTTMEN1
SCHEMBL17495017 0.74 NPC1 (0.46) KMT2AHTTMEN1NPC1LMNA
SCHEMBL14857828 0.74 PRMT5 (0.38) PRMT5WDR77CXCR2CXCR1KMT2A
Hydrochloric Acid SCHEMBL4012346 0.74 KMT2A (0.63) CXCR2CXCR1KMT2AHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
EP-4013508-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES Bayer Aktiengesellschaft (DE) 2022-06-22 EP disclosed
WO-2021028382-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2021-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES AHR, HRH4, HRH1 PRMT5 122/4885WDR77 1053/4885CXCR2 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.